Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Javier Martinez

Showing results (381-390 of 600) with videos related to

Pageof 60
Sort By:
Frontiers in Immunology|November 6, 2025
Immune and senescence profiles associated with non-AIDS-defining cancer risk in people with HIV: a case-cohort studyCarlos Pita-Martínez, María Ángeles Jiménez-Sousa, Javier Martinez-Picado, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|May 16, 2024
Preclinical development of humanized monoclonal antibodies against CD169 as a broad antiviral therapeutic strategyPatricia Resa-Infante, Itziar Erkizia, Xabier Muñiz-Trabudua, et al.
Research Square|June 12, 2026
First-line dolutegravir/lamivudine penetrates lymph nodes and reduces HIV reservoirs comparably to triple therapyJose Molto, Elias Rosen, Stephen Bondoc, et al.
Journal of Clinical Medicine|December 23, 2022
A Novel PiRNA Enhances CA19-9 Sensitivity for Pancreatic Cancer Identification by Liquid BiopsyWeiyao Li, Miguel Gonzalez-Gonzalez, Lara Sanz-Criado, et al.
Cardiology Journal|November 21, 2023
STRUGGLE FOR. Italian-Polish-Spanish-Uzbek-Vietnamese Expert Forum Position Paper 2023 for better control of classical modifiable risk factors in clinical practiceKrzysztof J Filipiak, Vivencio Barrios, Claudio Ferri, et al.
The Journal of General Virology|July 18, 2003
A novel TaqMan real-time PCR assay to estimate ex vivo human immunodeficiency virus type 1 fitness in the era of multi-target (pol and env) antiretroviral therapyJan Weber, Hector R Rangel, Bikram Chakraborty, et al.
Antimicrobial Agents and Chemotherapy|April 25, 2007
AM3 modulates dendritic cell pathogen recognition capabilities by targeting DC-SIGNDiego Serrano-Gómez, Rocío T Martínez-Nuñez, Elena Sierra-Filardi, et al.
Plos Pathogens|November 3, 2011
Deep molecular characterization of HIV-1 dynamics under suppressive HAARTMaria J Buzón, Francisco M Codoñer, Simon D W Frost, et al.
Journal of Clinical Medicine|April 14, 2026
Retinal Microvascular Features Assessed by Optical Coherence Tomography Angiography in Attention Deficit Hyperactivity DisorderCarmen Miquel-Lopez, Jose Javier Garcia-Medina, Antonio Eusebio Lopez-Hernandez, et al.
Journal of Internal Medicine|March 28, 2022
Altered T-cell subset distribution in the viral reservoir in HIV-1-infected individuals with extremely low proviral DNA (LoViReTs)Cristina Gálvez, Víctor Urrea, Maria Del Carmen Garcia-Guerrero, et al.
Pageof 60

Showing results (381-390 of 600) with videos related to

Sort By:
Pageof 60
Frontiers in Immunology|November 6, 2025
Immune and senescence profiles associated with non-AIDS-defining cancer risk in people with HIV: a case-cohort studyCarlos Pita-Martínez, María Ángeles Jiménez-Sousa, Javier Martinez-Picado, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|May 16, 2024
Preclinical development of humanized monoclonal antibodies against CD169 as a broad antiviral therapeutic strategyPatricia Resa-Infante, Itziar Erkizia, Xabier Muñiz-Trabudua, et al.
Research Square|June 12, 2026
First-line dolutegravir/lamivudine penetrates lymph nodes and reduces HIV reservoirs comparably to triple therapyJose Molto, Elias Rosen, Stephen Bondoc, et al.
Journal of Clinical Medicine|December 23, 2022
A Novel PiRNA Enhances CA19-9 Sensitivity for Pancreatic Cancer Identification by Liquid BiopsyWeiyao Li, Miguel Gonzalez-Gonzalez, Lara Sanz-Criado, et al.
Cardiology Journal|November 21, 2023
STRUGGLE FOR. Italian-Polish-Spanish-Uzbek-Vietnamese Expert Forum Position Paper 2023 for better control of classical modifiable risk factors in clinical practiceKrzysztof J Filipiak, Vivencio Barrios, Claudio Ferri, et al.
The Journal of General Virology|July 18, 2003
A novel TaqMan real-time PCR assay to estimate ex vivo human immunodeficiency virus type 1 fitness in the era of multi-target (pol and env) antiretroviral therapyJan Weber, Hector R Rangel, Bikram Chakraborty, et al.
Antimicrobial Agents and Chemotherapy|April 25, 2007
AM3 modulates dendritic cell pathogen recognition capabilities by targeting DC-SIGNDiego Serrano-Gómez, Rocío T Martínez-Nuñez, Elena Sierra-Filardi, et al.
Plos Pathogens|November 3, 2011
Deep molecular characterization of HIV-1 dynamics under suppressive HAARTMaria J Buzón, Francisco M Codoñer, Simon D W Frost, et al.
Journal of Clinical Medicine|April 14, 2026
Retinal Microvascular Features Assessed by Optical Coherence Tomography Angiography in Attention Deficit Hyperactivity DisorderCarmen Miquel-Lopez, Jose Javier Garcia-Medina, Antonio Eusebio Lopez-Hernandez, et al.
Journal of Internal Medicine|March 28, 2022
Altered T-cell subset distribution in the viral reservoir in HIV-1-infected individuals with extremely low proviral DNA (LoViReTs)Cristina Gálvez, Víctor Urrea, Maria Del Carmen Garcia-Guerrero, et al.
Pageof 60